BIFULCO, Maurizio
 Distribuzione geografica
Continente #
NA - Nord America 12.594
AS - Asia 10.290
EU - Europa 5.382
SA - Sud America 509
Continente sconosciuto - Info sul continente non disponibili 315
AF - Africa 95
OC - Oceania 9
Totale 29.194
Nazione #
US - Stati Uniti d'America 12.421
HK - Hong Kong 6.083
FI - Finlandia 2.006
SG - Singapore 1.727
IT - Italia 1.167
CN - Cina 1.054
VN - Vietnam 725
UA - Ucraina 628
RU - Federazione Russa 408
BR - Brasile 369
DE - Germania 315
SE - Svezia 223
IE - Irlanda 211
TR - Turchia 194
FR - Francia 162
KR - Corea 125
IN - India 109
GB - Regno Unito 76
CA - Canada 72
AR - Argentina 56
BD - Bangladesh 54
IQ - Iraq 43
MX - Messico 42
ES - Italia 37
JP - Giappone 31
NL - Olanda 29
ZA - Sudafrica 29
PL - Polonia 28
CZ - Repubblica Ceca 27
PK - Pakistan 23
VE - Venezuela 20
ID - Indonesia 18
CO - Colombia 16
JM - Giamaica 15
UZ - Uzbekistan 15
CR - Costa Rica 14
EC - Ecuador 13
DZ - Algeria 10
MA - Marocco 10
SA - Arabia Saudita 10
AT - Austria 9
KE - Kenya 9
BO - Bolivia 8
CH - Svizzera 8
CL - Cile 8
IL - Israele 8
LB - Libano 8
LT - Lituania 8
MY - Malesia 8
PY - Paraguay 8
TN - Tunisia 8
AE - Emirati Arabi Uniti 7
BE - Belgio 7
EU - Europa 7
JO - Giordania 7
HN - Honduras 6
NP - Nepal 6
PE - Perù 6
PH - Filippine 6
AU - Australia 5
EG - Egitto 5
ET - Etiopia 5
PA - Panama 5
PR - Porto Rico 5
AZ - Azerbaigian 4
BB - Barbados 4
BY - Bielorussia 4
GR - Grecia 4
NZ - Nuova Zelanda 4
OM - Oman 4
PS - Palestinian Territory 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
DO - Repubblica Dominicana 3
KG - Kirghizistan 3
MD - Moldavia 3
RO - Romania 3
UY - Uruguay 3
AO - Angola 2
CM - Camerun 2
GT - Guatemala 2
GY - Guiana 2
HU - Ungheria 2
IR - Iran 2
KH - Cambogia 2
LY - Libia 2
SN - Senegal 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
CG - Congo 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
Totale 28.867
Città #
Hong Kong 6.078
Dallas 2.961
Ann Arbor 2.161
Helsinki 1.875
Chandler 899
Singapore 874
San Jose 823
Jacksonville 753
Princeton 590
Woodbridge 540
Ashburn 436
Milan 432
Dong Ket 424
Wilmington 395
Houston 315
Council Bluffs 266
Dublin 211
Nanjing 194
Beijing 191
Izmir 170
Boardman 139
Lauterbourg 135
The Dalles 134
Andover 132
Pellezzano 118
Munich 116
Ho Chi Minh City 99
Rome 90
Salerno 81
Santa Clara 79
Los Angeles 77
Hanoi 75
Moscow 69
Nanchang 55
Shenyang 55
Fairfield 54
New York 52
Hebei 46
Jiaxing 44
Norwalk 42
Mestre 40
São Paulo 40
Changsha 36
Figino 36
Naples 32
Orem 32
Pune 31
Tokyo 30
Tianjin 27
Turin 26
Warsaw 26
Amsterdam 24
Brno 23
Memphis 23
Shanghai 22
Frankfurt am Main 21
Johannesburg 21
San Francisco 20
Seattle 20
Baghdad 19
Dearborn 19
Düsseldorf 19
Jinan 19
Mexico City 19
Stockholm 19
Turku 19
Brooklyn 18
Denver 17
Montreal 17
Chicago 16
London 16
San Diego 16
Atlanta 15
Boston 15
Columbus 15
Da Nang 15
Washington 15
Chennai 14
Haiphong 13
Nuremberg 13
Seoul 13
Brasília 12
Manchester 12
Qualiano 12
Redwood City 12
San José 12
West Jordan 12
Zhengzhou 12
Kingston 11
Phoenix 11
Tashkent 11
Cambridge 10
Mumbai 10
Poplar 10
Curitiba 9
Querétaro 9
Bari 8
Belo Horizonte 8
Guangzhou 8
Nairobi 8
Totale 23.368
Nome #
1,2-Dihydro-2-oxopyridine-3-carboxamides: The C-5 substituent is responsible for functionality switch at CB2 cannabinoid receptor 4.811
Genetic and pharmacologic inactivation of cannabinoid CB1 receptor inhibits angiogenesis 1.520
Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cells. 1.044
The endocannabinoid signaling system in cancer 892
Concomitant BRAFV600E mutation and RET/PTC rearrangement is a frequent occurrence in papillary thyroid carcinoma. 567
N6-isopentenyladenosine dual targeting of AMPK and Rab7 prenylation inhibits melanoma growth through the impairment of autophagic flux 525
Effects of olive oil polyphenols on fatty acid synthase gene expression and activity in human colorectal cancer cells. 500
Phytocannabinoids and cannabimimetic drugs: Recent patents in central nervous system disorders 349
Higher farnesyl diphosphate synthase activity in human colorectal cancer: inhibition of cellular apoptosis 347
The isoprenoid derivative N6-benzyladenosine (CM223) exerts antitumor effect in glioma patient-derived primary cells through the mevalonate pathway 334
Immuno-modulatory and anti-inflammatory effects of dihydrogracilin a, a terpene derived from the marine sponge Dendrilla membranosa 300
Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon 279
Exploring the putative role of PRDM1 and PRDM2 transcripts as mediators of T lymphocyte activation 276
Antiglioma effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, through the downregulation of epidermal growth factor receptor. 248
Structural Evidence ofN6-Isopentenyladenosine As a New Ligand of Farnesyl Pyrophosphate Synthase 229
Identification of CM223 as a new ligand of farnesyl pyrophosphate synthase with improved antiglioma action 229
Antitumor effect of pyrrolo-1,5-benzoxazepine-15 and its synergistic effect with Oxaliplatin and 5-FU in colorectal cancer cells. 226
Deregulated expression and activity of Farnesyl Diphosphate Synthase (FDPS) in Glioblastoma 211
Anandamide drives cell cycle progression through CB1 receptors in a rat model of synchronized liver regeneration. 199
Binding of the hemopressin peptide to the cannabinoid CB(1) receptor: structural insights. 198
Antiangiogenic effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, mediated by AMPK activation 193
Cannabidiol: State of the art and new challenges for therapeutic applications 179
Anti-tumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. 173
Anti Proliferative and Pro Apoptotic Effects of Flavonoid Quercetin Are Mediated by CB1 Receptor in Human Colon Cancer Cell Lines 173
Calcium/calmodulin-dependent protein kinase II (CaMKII) phosphorylates Raf-1 at serine 338 and mediates Ras-stimulated Raf-1 activation. 172
Dental care and dentistry practice in the Medieval Medical School of Salerno 172
Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients’ cells 169
Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects 167
A new strategy to block tumor growth by inhibiting endocannabinoid inactivation 164
Inhibition of Wnt/β-Catenin pathway and Histone acetyltransferase activity by Rimonabant: a therapeutic target for colon cancer 164
Interaction of endocannabinoid system and steroid hormones in the control of colon cancer cell growth. 163
Leucine enhances aerosol performance of Naringin dry powder and its activity on cystic fibrosis airway epithelial cells 161
Brain cancer risk: the weight of obesity 161
Association between Cannabinoid type-1 receptor polymorphism and body mass index in a Southern Italian population. Int J Obesity 158
Immunomodulatory properties of 1,2-dihydro-4-hydroxy-2-oxo-1,8-naphthyridine-3-carboxamide derivative VL15 158
Applicazione degli inibitori della prenilazione nelle patologie proliferative della tiroide: la lovastatina induce apoptosi in cellule tiroidee umane. 157
N6-isopentenyladenosine improves nuclear shape in fibroblasts from humans with progeroid syndromes by inhibiting the farnesylation of prelamin A 157
What we know and do not know about the cannabinoid receptor 2 (CB2) 156
Lovastatin induces apoptosis of k-ras-transformed thyroid cells via inhibition of ras farnesylation and by modulating redox state. 155
Arvanil and anandamide up-regulate CD36 expression in human peripheral blood mononuclear cells. 147
Apoptosis induced by denied adhesion to extracellular matrix (anoikis) in thyroid epithelial cells is p53 dependent but fails to correlate with modulation of p53 expression. 147
Cannabinoid Type 1 Receptor Gene Polymorphism and Macronutrient Intake. 147
The cannabinoid CB1 receptor antagonist Rimonabant stimulates 2-deoxyglucose uptake in skeletal muscle cells by regulating phosphatidylinositol-3-kinase activity. 146
Immune-Modulation and Properties of Absorption and Blood Brain Barrier Permeability of 1,8-Naphthyridine Derivatives. 143
Antiangiogenic activity of the endocannabinoid anandamide. Correlation to its tumour-suppressor efficacy 142
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity. 141
Thyroid adiponcosis: more than an hypothesis 140
The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits human breast cancer cell proliferation through a lipid raft-mediated mechanism. 140
Dietary and hypothyroid hypercholesterolemia induces hepatic apolipoprotein E expression in the rat: direct role of cholesterol. 136
A new role of anandamide in human sperm: focus on metabolism 136
17-beta estradiol overcomes a G1 block induced by HMG-CoA reductase inhibitors and fosters cell cycle progression without inducing Erk-1 and -2 MAP kinases activation 135
Biological and pharmacological roles of N6-isopentenyladenosine: an emerging anticancer drug 133
Anandamide inhibits Cdk2 and activates Chk1 leading to cell cycle arrest in human breast cancer cells. 132
“Adiponcosis”: A New Term to Name the Obesity and Cancer Link 129
Comment on “the negative impact of being underweight and weight loss on survival of children with acute lymphoblastic leukemia.” 129
Trotula e le piante medicinali mediterranee: dal Medioevo alla cosmetologia moderna 127
Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and of Ras farnesylation mediate antitumor effects of anandamide in human breast cancer cells. 127
Effects on immune cells of a new 1,8-naphthyridin-2-one derivative and its analogues as selective CB2 agonists: implications in multiple sclerosis 127
Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression 126
Molecular mechanisms responsible for neuroinflammation and neurological impairments in mevalonate kinase deficiency 125
Drug screening on Hutchinson Gilford progeria pluripotent stem cells reveals aminopyrimidines as new modulators of farnesylation 125
The isoprenoid end product N6-isopentenyladenosine reduces inflammatory response through the inhibition of the NFκB and STAT3 pathways in cystic fibrosis cells 124
A focus on Trotula de' Ruggiero: A pioneer in women's and children's health in history of medicine 123
Cannabinoid receptor 1 antagonism in hepatocellular carcinoma: Killing two birds with one stone 123
Updates on Adiponcosis: More new incoming evidence strengthening the obesity-cancer link 123
The right to care and the expectations of society?controversial stem cell therapy in Italy 122
Verminoside- and verbascoside-induced genotoxicity on human lymphocytes: involvement of PARP-1 and p53 proteins. 121
Statins and cancer-related mortality: an open question. 121
Breast adiponcosis: a call for further research 121
The medieval skincare routine according to the formulations of Madgistra Trotula and the Medical School of Salerno and its reflection on cosmetology of the third millennium 120
The basis of the modern medical hygiene in the medieval Medical School of Salerno 120
v-K-ras leads to preferential farnesylation of p21ras in FRTL-5 cells: multiple interference with the isoprenoid pathway 119
Modern History of Medical Cannabis: From Widespread Use to Prohibitionism and Back 119
Enrichment of CD56(dim)KIR + CD57 + highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patients 119
A metabolically stable analogue of anandamide, Met-F-AEA, inhibits human thyroid carcinoma cell lines by activation of apoptosis. 118
Serum withdrawal-induced apoptosis in thyroid cells is caused by loss of fibronectin-integrin interaction. 118
Cannabinoids and cancer: pros and cons of an antitumour strategy. 116
Mediterranean diet: The missing link between gut microbiota and inflammatory diseases 115
Statins and cancer in gastroenterology: new insight? 114
The HMG-CoA reductase inhibitor lovastatin induces apoptosis in proliferating human thyroid cells. 113
2',3'-Cyclic nucleotide 3'-phosphodiesterase: a membrane-bound, microtubule-associated protein and membrane anchor for tubulin 113
N(6)-isopentenyladenosine inhibits cell proliferation and induces apoptosis in a human colon cancer cell line DLD1 111
Cannabinoid receptor CB1 antagonists state of the art and challenges 111
Recognition by natural killer cells of N6-isopentenyladenosine-treated human glioma cell lines 111
Statin reduces orbitopathy risk in patients with Graves’ disease by modulating apoptosis and autophagy activities 110
N6-isopentenyladenosine affects cytotoxic activity and cytokines production by IL-2 activated NK cells and exerts topical anti-inflammatory activity in mice 107
Statins in neurological disorders: an overview and update 107
Rimonabant (SR141716) exerts anti-proliferative and immunomodulatory effects in human peripheral blood mononuclear cells. 106
Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents 106
Novel prospects of statins as therapeutic agents in cancer 105
Plasma membrane and lysosomal localization of CB1 cannabinoid receptor are dependent on lipid rafts and regulated by anandamide in human breast cancer cells. 104
Rimonabant: just an antiobesity drug? Current evidence on its pleiotropic effects. (review) 104
End of the line for cannabinoid receptor 1 as an anti-obesity target? An opinion. 104
Comment on 'When in Rome, reform'. 103
Rimonabant-induced apoptosis in leukemia cell lines: Activation of caspase-dependent and -independent pathways 102
Antibiotics exposure in obesity: an update of a complex relationship 101
The anandamide analogue, Met-F-AEA, controls human breast cancer cell migration via the RhoA/Rho kinase signaling pathway. 100
Multifaceted role of PRDM proteins in human cancer 100
Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB(1)/CB(2) receptors. 99
Modified Adenosines Sensitize Glioblastoma Cells to Temozolomide by Affecting DNA Methyltransferases 97
Totale 23.786
Categoria #
all - tutte 79.402
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.402


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.023 0 3 2 14 53 14 3 47 141 145 147 454
2022/20231.870 173 145 14 278 271 382 10 184 262 13 82 56
2023/2024670 68 105 42 30 48 114 14 28 8 35 49 129
2024/20251.870 116 27 106 99 79 184 310 170 269 70 204 236
2025/202616.363 2.521 3.062 3.814 446 809 396 1.083 252 2.356 749 162 713
2026/2027370 207 163 0 0 0 0 0 0 0 0 0 0
Totale 29.194